Clinical trials in Klaipeda – page 3

Innovative research focusing on systemic sclerosis, psoriatic arthritis, and ulcerative colitis. Studies are evaluating novel therapies including efgartigimod and sonelokimab to improve patient outcomes.

• Skin sclerosis treatment
• Joint inflammation management
• Gastrointestinal disorders

These trials aim to develop more effective treatments for chronic inflammatory conditions affecting multiple body systems.

Groundbreaking studies in multiple sclerosis treatment, particularly focusing on relapsing-remitting forms. Research includes comparative studies of new biologics and established treatments.

• Brain lesion reduction
• Disease progression management
• Long-term treatment efficacy

Clinical trials are exploring innovative approaches to improve neurological function and quality of life.

Studies targeting heart failure and atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiac events and improving heart function.

• Stroke prevention
• Heart failure management
• Cardiovascular risk reduction

Research focuses on both preventive measures and treatment of established cardiovascular conditions.

Advanced research in prostate cancer and bladder cancer, evaluating new treatment approaches including targeted therapies and hormone treatments.

• Non-invasive cancer treatments
• Metastatic disease management
• Novel therapeutic approaches

Trials aim to improve survival rates and quality of life for cancer patients.